United States Securities and Exchange Commission · EDGAR Accession 0002090859-26-000003

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2090859
Raising via StartEngine Primary, LLC

Barricade Therapeutics Corp.

CorporationDEIncorporated 2017Fort Worth, TXbarricadetherapeutics.com
A

The Offering

as disclosed in this filing
Other (Convertible Note)
$20,000
$1,235,000
April 30, 2026
Expired 45 days ago
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Revenue −75% YoYBurn increasingDebt / assets 4456%1 employee
Line itemMost recent FYPrior FYΔ
Revenue249,853988,125▼ 75%
Cost of goods sold00
Net income(935,689)(17,008)▼ burn
Total assets76,373725,114▼ 89%
Cash & equivalents10,832493,663▼ 98%
Accounts receivable00
Short-term debt433,543329,126▲ 32%
Long-term debt2,969,3122,786,781▲ 7%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.